Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akinobu Yoshimura

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|January 8, 2013
Clinical clerkship course for medical students on lumbar puncture using simulatorsKoji Adachi, Akinobu Yoshimura, Ryoko Aso, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 8, 2019
Association between F-18 fluorodeoxyglucose uptake of noncancerous lung area and acute exacerbation of interstitial pneumonia in patients with lung cancer after resectionTakashi Yamamichi, Yoshihisa Shimada, Ryuhei Masuno, et al.
The Annals of Thoracic Surgery|October 1, 2020
Impact of Glucose Uptake of Noncancerous Lung Area in Respiratory Events for Lung Cancer PatientsTakashi Yamamichi, Yoshihisa Shimada, Sachio Maehara, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 21, 2006
How wild-type TP53 is inactivated in undifferentiated-type gastric carcinomas: analyses of intratumoral heterogeneity in deletion and mutation of TP53Akinobu Yoshimura, Hiroyuki Sugihara, Zhi-Qiang Ling, et al.
Lung Cancer (Amsterdam, Netherlands)|September 11, 2009
Phase I/II study of docetaxel and S-1, an oral fluorinated pyrimidine, for untreated advanced non-small cell lung cancerYuichi Takiguchi, Yuji Tada, Akihiko Gemma, et al.
Anticancer Research|January 12, 2007
Weekly administration of irinotecan (CPT-11) plus cisplatin for non-small cell lung cancerMitsunori Hino, Kunihiko Kobayashi, Akinobu Yoshimura, et al.
Japanese Journal of Clinical Oncology|April 23, 2019
Treatment status and safety of crizotinib in 2028 Japanese patients with ALK-positive NSCLC in clinical settingsNaomi Ueno, Shigeo Banno, Yutaka Endo, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|July 21, 2004
Mutational analysis of the macrophage scavenger receptor 1 (MSR1) gene in primary lung cancerAkinobu Yoshimura, Akihiko Gemma, Kiyoko Kataoka, et al.
Lung Cancer (Amsterdam, Netherlands)|May 25, 2010
The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumoniasYuji Minegishi, Junko Sudoh, Hideaki Kuribayasi, et al.
Cancer Science|April 14, 2010
Histone deacetylase inhibitor enhances sensitivity of non-small-cell lung cancer cells to 5-FU/S-1 via down-regulation of thymidylate synthase expression and up-regulation of p21(waf1/cip1) expressionRintaro Noro, Akihiko Miyanaga, Yuji Minegishi, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|January 8, 2013
Clinical clerkship course for medical students on lumbar puncture using simulatorsKoji Adachi, Akinobu Yoshimura, Ryoko Aso, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 8, 2019
Association between F-18 fluorodeoxyglucose uptake of noncancerous lung area and acute exacerbation of interstitial pneumonia in patients with lung cancer after resectionTakashi Yamamichi, Yoshihisa Shimada, Ryuhei Masuno, et al.
The Annals of Thoracic Surgery|October 1, 2020
Impact of Glucose Uptake of Noncancerous Lung Area in Respiratory Events for Lung Cancer PatientsTakashi Yamamichi, Yoshihisa Shimada, Sachio Maehara, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 21, 2006
How wild-type TP53 is inactivated in undifferentiated-type gastric carcinomas: analyses of intratumoral heterogeneity in deletion and mutation of TP53Akinobu Yoshimura, Hiroyuki Sugihara, Zhi-Qiang Ling, et al.
Lung Cancer (Amsterdam, Netherlands)|September 11, 2009
Phase I/II study of docetaxel and S-1, an oral fluorinated pyrimidine, for untreated advanced non-small cell lung cancerYuichi Takiguchi, Yuji Tada, Akihiko Gemma, et al.
Anticancer Research|January 12, 2007
Weekly administration of irinotecan (CPT-11) plus cisplatin for non-small cell lung cancerMitsunori Hino, Kunihiko Kobayashi, Akinobu Yoshimura, et al.
Japanese Journal of Clinical Oncology|April 23, 2019
Treatment status and safety of crizotinib in 2028 Japanese patients with ALK-positive NSCLC in clinical settingsNaomi Ueno, Shigeo Banno, Yutaka Endo, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|July 21, 2004
Mutational analysis of the macrophage scavenger receptor 1 (MSR1) gene in primary lung cancerAkinobu Yoshimura, Akihiko Gemma, Kiyoko Kataoka, et al.
Lung Cancer (Amsterdam, Netherlands)|May 25, 2010
The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumoniasYuji Minegishi, Junko Sudoh, Hideaki Kuribayasi, et al.
Cancer Science|April 14, 2010
Histone deacetylase inhibitor enhances sensitivity of non-small-cell lung cancer cells to 5-FU/S-1 via down-regulation of thymidylate synthase expression and up-regulation of p21(waf1/cip1) expressionRintaro Noro, Akihiko Miyanaga, Yuji Minegishi, et al.
Pageof 6